KR890009385A - 피막 형성성 항진균제 조성물 - Google Patents

피막 형성성 항진균제 조성물 Download PDF

Info

Publication number
KR890009385A
KR890009385A KR1019880016351A KR880016351A KR890009385A KR 890009385 A KR890009385 A KR 890009385A KR 1019880016351 A KR1019880016351 A KR 1019880016351A KR 880016351 A KR880016351 A KR 880016351A KR 890009385 A KR890009385 A KR 890009385A
Authority
KR
South Korea
Prior art keywords
antifungal composition
acid ester
film forming
encapsulating
fatty acid
Prior art date
Application number
KR1019880016351A
Other languages
English (en)
Other versions
KR970001701B1 (ko
Inventor
이즈미 사이또
가오리 이께다
요시오 도이
쇼헤이 에가와
Original Assignee
요오또시 가즈오
시오노기세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요오또시 가즈오, 시오노기세이야꾸 가부시끼가이샤 filed Critical 요오또시 가즈오
Publication of KR890009385A publication Critical patent/KR890009385A/ko
Application granted granted Critical
Publication of KR970001701B1 publication Critical patent/KR970001701B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

피막 형성성 항진균제 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
종축은 피부내 TOL양을 나타내는 반면, 횡축은 시간을 나타낸다.
피부내 TOL 잔류량은 대조군에 대해서 “●”표로 실시예 1의 조성물에 대해서는 “○”표로 나타낸다.

Claims (5)

  1. 알콕시 용매중에 약 0.1% 내지 약 1.5%의 톨나프테이트, 약 10% 내지 약 20%의 디메틸아미노에틸 메탈크릴레이트-메타크릴산 에스테르 공중합체 및 0.5% 내지 약 10%의 중간 사슬 지방산 에스테르를 필수적으로 함유하지만 실제로 물을 함유하진 않는 피막형성성 항진균제 조성물.
  2. 제1항에 있어서, 중간 사슬지방산 에스테르가 테트라 글리세릴 모노카프레이트이 피막 형성성 항진균제 조성물.
  3. 제1항에 있어서, 약 0.1% 내지 약5%의 농화제를 더 함유하는 피막 형성성항진균제 조성물.
  4. 제1항에 있어서, 상기 알콜성 용매가 에탄올 또는 이소프로판올인 피막 형성성 항진균데 조성물.
  5. 제3항에 있어서, 농화제가 에틸셀로스, 히드록시프로필 셀룰로스 또는 히드록시프로필메틸셀룰로스인 피막형성성 항진균제 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880016351A 1987-12-08 1988-12-08 피막 형성성 항진균제 조성물 KR970001701B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP310480/1987 1987-12-08
JP62310480A JPH07116035B2 (ja) 1987-12-08 1987-12-08 被膜形成性抗真菌剤組成物

Publications (2)

Publication Number Publication Date
KR890009385A true KR890009385A (ko) 1989-08-01
KR970001701B1 KR970001701B1 (ko) 1997-02-14

Family

ID=18005744

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880016351A KR970001701B1 (ko) 1987-12-08 1988-12-08 피막 형성성 항진균제 조성물

Country Status (8)

Country Link
US (1) US4915940A (ko)
EP (1) EP0319964B1 (ko)
JP (1) JPH07116035B2 (ko)
KR (1) KR970001701B1 (ko)
AT (1) ATE73675T1 (ko)
DE (1) DE3869355D1 (ko)
ES (1) ES2032323T3 (ko)
GR (1) GR3004551T3 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
US5026554A (en) * 1990-09-13 1991-06-25 Merck & Co., Inc. Method of inhibiting fungal growth using squalene synthetase inhibitors
KR100244554B1 (ko) * 1991-10-16 2000-04-01 린다데이로하르 비이온성폴리아크릴아미드유도체를함유하는낮은ph의수성화장용겔
EG20380A (en) 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
HUT74560A (en) * 1991-10-16 1997-01-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
KR950702436A (ko) * 1992-07-28 1995-07-29 자코부스 코르넬리스 라세르 가교 결합 양이온성 중합체 및 알콜실화 에테르를 함유하는 국소용 약학 조성물(pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether)
US5989536A (en) * 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
WO1995030409A1 (en) * 1994-05-05 1995-11-16 Merck Frosst Canada Inc. Topical polymeric drug delivery system
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
CA2265774C (en) 1996-06-24 2009-05-05 Bio-Safe Enterprises, Inc. Antibacterial composition
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
AU2002343739A1 (en) * 2001-11-14 2003-05-26 Medlogic Global Limited Improved therapy for topical diseases
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
JP5059408B2 (ja) * 2004-08-05 2012-10-24 久光製薬株式会社 爪用外用剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1186691A (en) * 1967-03-30 1970-04-02 Edward Henderson Antiseptic Compositions
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US3989815A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Novel N-bis-azacyclopentan-2-onyl alkanes
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPH08159425A (ja) * 1994-12-08 1996-06-21 Wataru Momose 溶融炉

Also Published As

Publication number Publication date
ES2032323T3 (es) 1993-02-01
DE3869355D1 (de) 1992-04-23
ATE73675T1 (de) 1992-04-15
KR970001701B1 (ko) 1997-02-14
US4915940A (en) 1990-04-10
JPH01149722A (ja) 1989-06-12
GR3004551T3 (ko) 1993-04-28
EP0319964B1 (en) 1992-03-18
EP0319964A1 (en) 1989-06-14
JPH07116035B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
KR890009385A (ko) 피막 형성성 항진균제 조성물
KR890014104A (ko) 심장과 심맥관계에 특히 작용하는 약학적 조성과 이의 제조방법 공정
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
KR940013497A (ko) 소염진통겔 제제
KR880013557A (ko) 신규 안과용 조성물
KR890009391A (ko) 무좀 치료제
SE8802281D0 (sv) Mellanprodukt for framstellning av derivat av n-arylerad oxazolidin-2-on
KR890013520A (ko) 네가형 감광성 수지 조성물
KR890003368A (ko) 특정의 치환된 페닐알킬아미노(및 아미노산) 유도체 및 기타 세로토닌농도 저하제로 오심 및 구토를 치료하는 방법
KR890009388A (ko) 비타민 e 배합 외용제
GB1310140A (en) Hair setting and fixing agent
KR970032514A (ko) 솔 식초 및 이를 함유하는 음료 조성물
JPS54140739A (en) Pretreating agent for hair coloring
KR900000455A (ko) 자외선을 흡수하는 시클로헥센일리덴 조성물
JPS57112306A (en) Antifungal agent composition
GB1382427A (en) Composition and method for strengthening nails
KR960006929A (ko) 좀담배풀 추출물을 유효성분으로 하는 갑상선 질환 치료용 약제
KR860000018A (ko) 감의 코오팅 처리방법
KR920011492A (ko) 시플로플록사신의 주사용 조성물 및 그 제조방법
KR950007838A (ko) 은행잎 엑기스 연질캅셀제 및 그의 제조방법
KR910700043A (ko) 타정시에 있어서 응력분산 방법
KR970032513A (ko) 알로에 식초 및 이를 함유하는 음료 조성물
KR830003908A (ko) 코티코스테로이드 물질을 함유하는 약학조성물
KR940000109A (ko) 녹용엑기스 함유 연질캅셀

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040709

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee